eli lilly tirzepatide fda approval Lilly's is off the FDA's drug shortage list: Here's what it means Novo sues Lilly, claiming misleading

If you notice mild tenderness at the injection site, that usually fades quickly

Even the FDA acknowledged that "patients and prescribers may still see intermittent and limited localized supply disruptions as the products move through the supply chain from the manufacturer and distributors to local pharmacies." The American Society of Health-System Pharmacists' shortage list continues to show both semaglutide and tirzepatide injection in shortage

GLP-1/GIP Receptor Agonists : Taking other GLP-1 receptor agonists (Semaglutide, Liraglutide, or Dulaglutide) with Tirzepatide is not recommended due to overlapping effects and increased side effect risks

Aon, which piloted a similar eMed program for its own employees, reported that participants stayed on the medication longer and saw meaningful improvements in weight and BMI